| NCT ID | NCT02504489 |
| Title | Plinabulin (P) + Docetaxel (D) vs D as 2nd-Line Chemo in Patients With Advanced NSCLC With at Least 1 Large Lung Lesion |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | yes |
| Sponsors | BeyondSpring Pharmaceuticals Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |